Deployment of our classification pipeline showed that the top five most occurring effects having a strong relation (classification level 2) with ADAM33 were asthma, chronic obstructive pulmonary disease (COPD), lung function, allergic rhinitis, and airway remodelling. This evidence concerns the gene ADAM33 and allergic rhinitis.